Document is current
Any future updates will be listed below
-
Authors
Dei Cas, A. https://orcid.org/0000-0002-8666-4849
Micheli, M. M.
Aldigeri, R.
Gardini, S.
Ferrari-Pellegrini, F.
Perini, M.
Messa, G.
Antonini, M.
Spigoni, V.
Cinquegrani, G.
Vazzana, A.
Moretti, V.
Caffarra, P.
Bonadonna, R. C.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03881371 at ClinicalTrials.govDocuments that mention this clinical trial
The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson’s Disease
https://doi.org/10.1007/s12325-023-02736-2
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial
https://doi.org/10.1007/s40618-024-02320-7
-
Funding
Funding for this research was provided by:
Diabetes Research Innovation (DRINN project)
Università degli Studi di Parma
- License Information
-
More Information
Article History
Received: 5 December 2023
Accepted: 23 January 2024
First Online: 2 April 2024
Declarations
:
: The authors declare no conflict of interest.
: The study was approved by the Ethics Committee “Comitato Etico per Parma” (Protocol number 34790, date of approval 16-sept-2015). Written informed consent was obtained from all subjects involved in the study.
: Written informed consent to publish was obtained from all subjects involved in the study.
